The efficacy of febuxostat is mainly to lower uric acid, the specific use of medication as prescribed by the doctor.
Febuxostat is a commonly used xanthine oxidase inhibitor class of uric acid drugs, can inhibit uric acid synthesis, and thus reduce the serum urea concentration, mainly for long-term treatment of gout patients with hyperuricemia.
The drug is mainly prohibited in patients who are allergic to the product, patients who are receiving azathioprine or mercaptopurine treatment. Common adverse reactions that may occur during treatment with this medication include abnormal liver function, joint pain, rash, and nausea. Specific medications related to febuxostat should be used under the guidance of a medical specialist and should not be used without authorization.